Literature DB >> 23861552

Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36.

Jin-Lian Chen1, Xiao-Jie Lu, Kai-Lin Zou, Kun Ye.   

Abstract

The Krüppel-like factor (KLF) family of transcription factors regulates diverse biological processes that include proliferation, differentiation, apoptosis, development, and responses to external stress. In the present study, we aim to investigate the roles of KLF2 in hepatic steatosis. Our results showed that mRNA and protein levels of KLF2 were significantly elevated in livers from obese mice. Adenoviruses-mediated overexpression of KLF2 induced accumulation of triglycerides in C57BL/6 mice, whereas KLF2 silencing ameliorates hepatosteatosis in ob/ob mice. At the molecular level, our data established CD36 as a novel transcriptional target of KLF2. KLF2 upregulated CD36 expression through a consensus binding site on its proximal promoter region. Additionally, the steatotic effect of KLF2 was dramatically inhibited in CD36-null mice. Therefore, our study reveals a novel link between KLF2-induced hepatic triglyceride accumulation and the expression of CD36.

Entities:  

Keywords:  Krüppel-like factor 2; fatty acid uptake; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2013        PMID: 23861552      PMCID: PMC3927469          DOI: 10.1194/jlr.M039453

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Jing Feng; Douglas Befroy; James Dziura; Chiara Dalla Man; Claudio Cobelli; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice.

Authors:  Hiroyuki Tsuchiya; Yoshito Ikeda; Yu Ebata; Chihiro Kojima; Rikutaro Katsuma; Tatsuaki Tsuruyama; Tomohiko Sakabe; Kohei Shomori; Noriko Komeda; Shoko Oshiro; Hideharu Okamoto; Kazuko Takubo; Susumu Hama; Koichi Shudo; Kentaro Kogure; Goshi Shiota
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

3.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid.

Authors:  Pascal Degrace; Bastien Moindrot; Ismaël Mohamed; Joseph Gresti; Zhen-Yu Du; Jean-Michel Chardigny; Jean-Louis Sébédio; Pierre Clouet
Journal:  J Lipid Res       Date:  2006-09-06       Impact factor: 5.922

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Authors:  Mitsutaka Inoue; Takaaki Ohtake; Wataru Motomura; Nobuhiko Takahashi; Yayoi Hosoki; Shigeki Miyoshi; Yasuaki Suzuki; Hiroyuki Saito; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

7.  Splanchnic lipolysis in human obesity.

Authors:  Soren Nielsen; ZengKui Guo; C Michael Johnson; Donald D Hensrud; Michael D Jensen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.

Authors:  Giusi Marrone; Lucia Russo; Eugenio Rosado; Diana Hide; Guillermo García-Cardeña; Juan Carlos García-Pagán; Jaime Bosch; Jorge Gracia-Sancho
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

9.  A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway.

Authors:  Jie Zhou; Yonggong Zhai; Ying Mu; Haibiao Gong; Hirdesh Uppal; David Toma; Songrong Ren; Ronald M Evans; Wen Xie
Journal:  J Biol Chem       Date:  2006-03-23       Impact factor: 5.157

10.  Krüppel-like factor 2 is required for normal mouse cardiac development.

Authors:  Aditi R Chiplunkar; Tina K Lung; Yousef Alhashem; Benjamin A Koppenhaver; Fadi N Salloum; Rakesh C Kukreja; Jack L Haar; Joyce A Lloyd
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more
  13 in total

1.  Krüppel-like factor 2 promotes cell proliferation in hepatocellular carcinoma through up-regulation of c-myc.

Authors:  Kailin Zou; Xiaojie Lu; Kun Ye; Chunmei Wang; Tiangeng You; Jinlian Chen
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

Review 2.  The Krüppel-Like Factors and Control of Energy Homeostasis.

Authors:  Paishiun N Hsieh; Liyan Fan; David R Sweet; Mukesh K Jain
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

3.  The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Reinhard Spanel; Florian Länger; Hyoung-Yun Han; Eun-Hee Lee; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-09-23

4.  Unexpected metabolic disorders induced by endocrine disruptors in Xenopus tropicalis provide new lead for understanding amphibian decline.

Authors:  Christophe Regnault; Marie Usal; Sylvie Veyrenc; Karine Couturier; Cécile Batandier; Anne-Laure Bulteau; David Lejon; Alexandre Sapin; Bruno Combourieu; Maud Chetiveaux; Cédric Le May; Thomas Lafond; Muriel Raveton; Stéphane Reynaud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

Review 5.  Krüppel-like factors in glycolipid metabolic diseases.

Authors:  Yutong Li; Xiaotong Zhao; Murong Xu; Mingwei Chen
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

6.  IRF2BP2: A New Player at the Crossroads of Inflammation and Lipid Metabolism.

Authors:  Hanrui Zhang; Muredach P Reilly
Journal:  Circ Res       Date:  2015-09-25       Impact factor: 17.367

7.  microRNA-32-5p targets KLF2 to promote gastric cancer by activating PI3K/AKT signaling pathway.

Authors:  Qingqing Wang; Yuan He; Weiqiong Kan; Fucai Li; Xiangjun Ji; Xuewen Wu; Xinyue Wang; Yue Zhang; Jinlian Chen
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

8.  Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.

Authors:  Pär Steneberg; Alexandros G Sykaras; Fredrik Backlund; Jurate Straseviciene; Ingegerd Söderström; Helena Edlund
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

9.  Krüppel-like factors: Crippling and un-crippling metabolic pathways.

Authors:  Nina M Pollak; Matthew Hoffman; Ira J Goldberg; Konstantinos Drosatos
Journal:  JACC Basic Transl Sci       Date:  2018-03-01

Review 10.  Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease.

Authors:  Yumiko Oishi; Ichiro Manabe
Journal:  Front Cardiovasc Med       Date:  2018-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.